Page last updated: 2024-08-23

edatrexate and Colonic Neoplasms

edatrexate has been researched along with Colonic Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Iijima, A; Kitoh, K; Kotake, Y; Koyanagi, N; Nomura, H; Ozawa, Y; Tamai, N; Yoshimatsu, K1
Otter, GM; Schmid, FA; Sirotnak, FM1
Israel, K; Kemeny, N; O'Hehir, M1

Other Studies

3 other study(ies) available for edatrexate and Colonic Neoplasms

ArticleYear
Synthesis and antitumor activities of novel 6-5 fused ring heterocycle antifolates: N-[4-[omega-(2-amino-4-substituted-6,7-dihydrocyclopenta [d]pyrimidin-5-yl)alkyl]benzoyl]-L-glutamic acids.
    Journal of medicinal chemistry, 1994, May-27, Volume: 37, Issue:11

    Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Division; Colonic Neoplasms; Folic Acid Antagonists; Glutamates; Humans; Leukemia P388; Methotrexate; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Mice, Nude; Neoplasm Transplantation; Pyrimidines; Structure-Activity Relationship; Tumor Cells, Cultured

1994
Markedly improved efficacy of edatrexate compared to methotrexate in a high-dose regimen with leucovorin rescue against metastatic murine solid tumors.
    Cancer research, 1993, Feb-01, Volume: 53, Issue:3

    Topics: Adenocarcinoma; Aminopterin; Animals; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fibrosarcoma; Leucovorin; Lung Neoplasms; Mammary Neoplasms, Experimental; Melanoma, Experimental; Methotrexate; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental; Salvage Therapy

1993
Phase II trial of 10-Edam in patients with advanced colorectal carcinoma.
    American journal of clinical oncology, 1990, Volume: 13, Issue:1

    Topics: Abdominal Pain; Adult; Aged; Aminopterin; Carcinoma; Colonic Neoplasms; Drug Evaluation; Female; Folic Acid Antagonists; Humans; Injections, Intravenous; Male; Middle Aged; Rectal Neoplasms; Remission Induction

1990